EFFICACY OF RASON, ASHWAGANDHA AND ASHWATHA IN DIABETIC ERECTILE DYSFUNCTION â€“ A CRITICAL REVIEW by Soni, *Pradeeep & Sharma, P.L.
ISSN: 2322 - 0902 (P) 
ISSN: 2322 - 0910 (O) 
 IJAPR | March 2017 | Vol 5 | Issue 3  95 
International Journal of Ayurveda  
and Pharma Research 
 
Review Article 
 
 
EFFICACY OF RASON, ASHWAGANDHA AND ASHWATHA IN DIABETIC ERECTILE DYSFUNCTION – A 
CRITICAL REVIEW  
Pradeep Soni1*, P.L.Sharma2 
*1Lecturer, P.G. Department of Dravyaguna, M.M.M.Govt.Ayurved College Udaipur, Rajasthan, India. 
2Associate Professor, Department of Agad Tantra, M.M.M.Govt.Ayurved College Udaipur, Rajasthan, India. 
ABSTRACT 
Background: Erectile dysfunction (ED) is a common condition among men with diabetes and it is 
associated with reduced quality of life among those affected. ED has reported to increase with age, 
increasing from 5% at 40 years to > 50 % at 75 years of age. The incidence of ED is increasing day by day 
with the incidence of diabetes and the prevalence of ED is estimated between 35-50%. Erectile 
Dysfunction (ED); inability to achieve and/or maintaining an erection sufficient to permit satisfactory 
sexual intercourse, is one of complication associated with diabetes and often ignored. ED problem is 
‘psycho-organic’, because it affects the man as whole. The diabetes and oxidative stress are major 
contributors for ED. Objective: Though there are many medicinal plants shows the antidiabetic and 
related to beneficial effect in ED. Among those medicinal plants we selected and reviewed Rason (Allium 
sativum Linn.), Ashwagandha (Withania somnifera Dunal) and Ashwatha (Ficus religiosa Linn.) To assess 
and find out the antidiabetic effect and their efficacy in ED. Research methods and procedure: In the 
present study, we collected and compiled (Various research journals) the references regarding previous 
work done on antidiabetic effect of above mentioned medicinal plants w.s.r. to E.D. Discussion & 
Conclusion: on the basis of our literary review it is concluded that the Rason (Allium sativum), 
Ashwagandha (Withania somnifera) and Ashwatha (Ficus religiosa) are responsible for significant 
antidiabetic effect with the hypoglycemic property and also exhibit the efficacy in ED due to aphrodisiac 
properties.  
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INTRODUCTION
The US National Institute of Health define Erectile 
dysfunction (ED) is the persistent inability of a man to 
attain or maintain sufficient erection required for 
satisfactory sexual activity[1]. ED is becoming quite 
frequent in diabetes patients. There are mainly two types 
of ED primary, where sexual function is quite normal, or 
secondary, in which case sexual abnormality occurs after a 
period of normal sexual activity: in diabetic patients 
invariably is ED secondary. Erectile dysfunction (ED) is a 
common condition in diabetic men. Erectile Dysfunction is 
two or three times more common in Diabetics than in 
General population. Incidence of Erectile Dysfunction is 
nearly 65% in men with Diabetes of more than 10 yrs of 
duration [2]. Erectile Dysfunction has been the most 
neglected complication of diabetes. ED has reported to 
increase with age, increasing from 5% at 40 years to > 50 
% at 75 years of age. The incidence of ED is increasing day 
by day with the incidence of diabetes and the prevalence of 
ED is estimated in India between 35-50% [1]. Diabetic men 
tend to develop ED 10 to 15 years earlier than non- 
diabetic men. Where approximately 52% of ED is 
prevalent in the non diabetic men between the ages of 40 
to 70 years, in diabetic men it ranges from 35% to 75% 
that begins at an earlier age. After 70 years of age, 2/3rd of 
the general male population is diagnosed with ED. The 
occurrence of ED in diabetic men between 20-29 years of 
age is only 9% that rises to 95% by 70 years of age. It was 
found that erectile dysfunction occurs within 10 years of 
the onset of diabetes in 50% of diabetic men [3]. The 
presence of diabetes mellitus not only increases the risk 
for ED but can other aspects of sexual disorders such as 
sexual drive, PME (Premature ejaculation), and sexual 
satisfaction[4]. Diabetic ED is multifactorial in 
pathophysiology and the mechanism is proposed that 
glucose itself and hyperglycemia increases protein 
glycosylation producing advanced glycation end products 
(AGEs)[5]. Medicinal plants are being looked up for the 
treatment of diabetes and its complications. Important 
herbs/medicinal plants are being used traditionally in 
India for their anti-diabetic and aphrodisiac effect. These 
herbs/medicinal plants could be promising candidates for 
exploring their potential in the treatment of diabetic ED, 
due to their combined effect on diabetes and ED.  
The aim of the present review study is to provide 
an update on the epidemiology, patho-physiology and 
assess the anti-diabetic effect of Rason (Allium sativum), 
Ashwagandha (Withania somnifera) and Ashwatha (Ficus 
religiosa) and their efficacy in ED. 
MATERIAL AND METHODS 
Details of articles, books and internet related to 
diabetes and ED and efficacy of selected herbs in the 
management of diabetic ED are reviewed. Older studies 
were included selectively if relevant and data regarding 
treatment and result reviewed. Here, an attempt has been 
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made to gathered those scattered reporting from various 
published research articles and books related to efficacy of 
selected herbs in diabetes and ED. 
EPIDEMIOLOGY 
Diabetes, which is strongly associated with 
changing life style, is reaching pandemic level. Due to life 
style and food habit changes are the major cause for the 
diabetes. Indeed, the world diabetic population is expected 
to reach 366 million by the year 2030[6]. In India, it is 
estimated to be 58%, from 51 million people in 2010 to 87 
million in 2030[7]. And among these diabetic people, more 
than 50% have sexual troubles caused by their disease. 
The incidence of ED is higher in patients taking diabetic 
treatment. 
Etiology and Patho-Physiology of Ed in Diabetes 
The patho-physiology of ED in diabetic men is 
multifactorial and no single cause is reasonable. Diabetes 
further rises to development of advance glyceted end 
products (AGEs). Generally, the formation of AGEs is based 
upon the non enzymatic reaction between glucose and 
lipoprotein or nucleic acid[8] which leads to decrease 
thickening, elasticity, increase atherosclerosis and 
conversion in endothelial function[9].  
The relationship between AGEs with diabetic ED is 
based on generation of free radical oxygen which comes 
from quenching of NO and oxidative cell damage have 
major role in relaxation of cavernosum smooth muscle. 
High levels of effects are particularly seen on the 
potassium channel which is mainly responsible for 
subsequent relaxation of cavernosal smooth muscles and 
intracellular facilitation of the release of calcium. Early 
development of diabetic ED takes place on damage of 
potassium channels[10].  
Erection is a neurological phenomena and ED can 
be developed due to dysfunction of pudendal nerve or 
their terminal branches. Somatic and autonomic nerve 
dysfunction can be demonstrated in diabetic men who 
have longer latency somatosensory-evoked potentials of 
the pudendal nerve and bulb cavernous and urethronal 
reflexes[11]. Recent researches have shown that the 
transduction pathway for endothelial involving GTP-
binding protein, Rho-kinase, RhoA and its effectors agent 
might play a role in development of diabetic ED. It is 
suggested that the RhoA/Rho-kinase pathway interfere ED 
through decreased production of NO in the penis[12].  
 Impairment of Cyclic Guanosine Mono Phosphate 
(cGMP) plays an important role in ED in diabetes. The 
formation of cGMP does not going to interfere with NO in 
relaxation of the corpus cavernosum12 whereas the high 
level of superoxide radicals present at cavernosal tissue. 
DIED have decreased level of NO synthase that results into 
another possible pathways leading to smooth muscle and 
cavernosal dysfunction[13]. It is also hypothesized that 
guanylyl cyclase activity impairs in DM by decreased 
production of cGMP. Furthermore, ineffective endothelial 
dysfunction rapidly delivers the functional syncytium of 
the corpora cavernosa that leads to decrease NO and cGMP 
that involve signicantly in the development of diabetes 
ED[14]. Elevated HbA1c level and the associated 
hyperglycemia in men with diabetes have been postulated 
to decrease NO activity and reduce endothelium-
dependent relaxation factors, resulting in an increase risk 
of ED. HbA1c level greater than 8.1% increase the incidence 
of ED threefold[15]. It is reported that diabetes have 
damaging effects on testosterone production which further 
effect on local endocrine transmitters by impaired LH 
response to GnRH stimulation of basal normal 
gonadotropin levels[16].  
MEDICIANL PLANTS EXPLORED IN DIABETIC E.D.  
Medicinal plants, since time immemorial, have 
been used in virtually all cultures as a source of medicine. 
It has been estimated that about 80-85% of population, 
both in developed and developing countries rely on 
traditional medicine for their primary health care needs 
and it is assumed that a major part of traditional therapy 
involves the use of plant extracts or their active 
principles[17].  
Rason (Allium sativum Linn.) 
Rason consists of bulb of Allium sativum Linn. 
(Fam. Liliaceae); a perennial bulbous plant, cultivated 
throughout India as an important condiment crop[18]. Raw 
cloves of Allium sativum Linn. have long been used as 
dietary supplement for traditional treatment of diabetes. 
Former is used as stimulant, diuretic and expectorant[19]. It 
consist volatile oil containing Allyl Disulphide and Diallyl 
Disulphide. It also contains Allin, Allicin, Mucilage and 
Albumin[18]. Allium sativum Linn. contains many sulphur 
containing compounds mainly in the form of cysteine 
derivatives viz. S-allyl cysteine sulphoxides which 
decompose into a variety of thiosulfinates and polysulfides 
by the action of enzyme allinase on extraction. 
Decomposed products are volatile and are present in the 
oil of garlic. They possess antidiabetic, 
hypocholesterolemic, fibrinolytic and various other 
biological actions[20]. A study on allicin, a sulfur containing 
compound, showed hypoglycemic activity[21] due to 
increased hepatic metabolism and increased insulin 
release from pancreatic beta cells[22]. Aqueous homogenate 
of Allium sativum (10ml/kg/day) administrated orally to 
sucrose fed rabbits (10g/kg/day) in water for two months 
significantly increased hepatic glycogen and free amino 
acid content, decreased fasting blood glucose[23]. Rason is 
also reported to have aphrodisiac property along with 
antidiabetic activity. Its cloves are used traditionally to 
enhance sexual power[24]. A study exhibited that extract of 
Allium sativum increases the weight of seminal vesicles 
and epididymides of male rates and also significantly 
increases the sperm count[25]. It is reported that the ability 
of Rason to increase both Nitric Oxide Synthesis (NOS) and 
the production of one of the essential cofactors- TBH for 
the enzyme, adds support to the claim that garlic can exert 
some of its therapeutic properties by increasing NO 
production in the body[26]. It was reported that Rason 
increase the activity of GTP-Cyclohydrolase-I enzyme, 
which is responsible for the synthesis of TBH 
(tetrahydrobioprotein) by GTP[27]. Rason increases in NOS 
activity depending on dose. The vascular endothelium has 
a primary regulatory role to keep the blood vessels dilated 
and NO is continuously released by vascular endothelial 
cells and regulates the blood flow and vasodilaiton. This 
release of NO appears to be shear stress and tone 
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dependent and this constitutes a local vascular reflex 
mechanism to sustain regional blood flow into vascular 
beds in the presence of intense sympathetic 
vasoconstriction[28]. It is reported in comparative study of 
Allium sativum and Sildenafil citrate; a drug to enhance the 
sexual activities and used in ED in western country, 
explored the result that Siladenafil citrate increases blood 
GMP level by inhibiting its degrading enzyme 
phosphodiesterase-5 (PDE-5), while Allium sativum act by 
activation of guanalyl cyclase enzyme and thus by 
increasing production of GMP in body[29]. 
Ashwatha (Ficus religiosa Linn.) 
Ficus religiosa Linn, commonly known as the 
Ashwath tree, belongs to the Moraceae family and found 
throughout India. The bark contains bergenin, leupin-3-
one, methyl oleoanolate, lanosterol, β-sitisteryl-
Dglucoside, stigmasterol. The bark is altrative, 
haemostatic, laxative, and bark is used for the treatment of 
diabetes[30]. A study showed that aqueous extract of Ficus 
religiosa bark was investigated in normal, glucose-loaded 
hyperglycemic and streptozotocin (STZ)-induced diabetic 
rats. Oral administration of Ficus religiosa bark aq.extract 
at the doses of 25, 50 and 100 mg/kg was studied in 
normal, glucose-loaded and STZ diabetic rats. The freshly 
prepared solutions were orally administered daily for 21 
days. The three doses caused significant reduction in blood 
glucose levels in all the models due to the phyto-
costituents given in Table.1. The effect was more 
pronounced in 50 and 100 mg/kg than 25 mg/kg. Ficus 
religiosa bark aq.extract also showed significant increase 
in serum insulin, body weight and glycogen content in liver 
and skeletal muscle of STZ-induced diabetic rats while 
there was significant reduction in the -levels of serum 
triglyceride and total cholesterol. Ficus religiosa bark 
aq.extract also showed significant anti lipidperoxidative 
effect in the pancreas of STZ induced diabetic rats. The 
results indicate that aqueous extract of Ficus religiosa bark 
possesses significant antidiabetic activity[31]. It was 
reported that a phytosterolin isolated from F. religiosa root 
bark when given at a dose of 25 mg/kg orally to fasting 
rabbits produced a maximum fall of the blood sugar level, 
equivalent to 81% of the tolbutamide standard, after 5-7.5 
mg/kg a maximum effect was achieved after 2 hour[32]. 
Aqueous extract of F. religiosa orally decreases the fasting 
blood glucose. F. religiosa modulates the enzymes of 
antioxidant defense system to combat oxidative stress .As 
a result glutathione was restored and inhibited the 
formation of malondialdehyde, proving its anti-diabetic 
activity along with antioxidant potential[33]. A clinical study 
carried out of F. religiosa root bark, stem bark, fruit and 
tender leaf buds powder was given to subjects in form of 
Kshirpak methods in diabetic erectile dysfunction for 45 
days. In this study it was investigated that 42.86% penile 
rigidity increase which is highly significant (P<0.001), 
8.7% improvement in penile erection. F. religiosa showed a 
highly significant in International Index of Erectile 
Function (IIEF) scoring[34].  
Ashwagandha (Withania somnifera Dunal) 
Withania somnifera Dunal; a small woody shrub, 
commonly known as Indian ginseng/ Ashwagandha , 
belongs to Solanaceae family, has been an important herb 
in the Ayurvedic and indigenous medical systems for over 
3000 years. Ayurved indicated it as a general tonic and 
aphrodisiac agent and it is used in various ailments. The 
roots of the plant are categorized as Rasayanas, which are 
routed to promote health and longevity by augmenting 
defense against disease, arresting the ageing process, 
revitalizing the body in debilitated conditions, increasing 
the capability of the individual to resist adverse 
environmental factors and creating a sense of mental well 
being[35]. Withania somnifera has been revealed as an 
immune stimulator and also an immune regulator in 
immune inflammation[36]. It is also credited to be 
hypoglycemic activity[37] in various experimental animal 
studies. The hypoglycemic activity of ethanolic root 
extracts of Withania somnifera was tested on 
streptozotocin treated diabetic sprayul rats over a period 
of three weeks and prominent hypoglycemic activity was 
reported in lowering blood glucose in type I diabetic 
model[38]. Hypoglycemic and hypolipidaemic effect of 
Withania somnifera root and leaf extract on Alloxan 
induced diabetic albino wistar strain rats has also been 
reported[39]. Antidiabetic activity of purified Withanolides 
obtained from hydroalcoholic extracts of dried berries was 
also reported[40]. Similarly, purified Withanolides of 
Withania somnifera revealed significant inhibition of post 
prandial rise in hypoglycaemia post sucrose load in SDZ 
induced diabetic rats[41]. In a clinical study it was 
investigated that 3gm/day root powder of Withania 
somnifera were given to the subjects for one month twice a 
day and result showed that 12% reduction in blood sugar 
level[42].  
In Ayurved the root of Ashwagandha is being used 
as an aphrodisiac and alterative. It is considered as 
Rasayan for strength, vigor and rejuvenation. It might have 
the effect by direct spermatogenic influence on the 
seminiferous tubules, presumably by exerting a 
testosterone like effect[43]. An animal study showed 
diabetes was induce by single dose (60mg/kg) of STZ in 
winstar male rats and orally withania somnifera root was 
given in pelleted food at ratio of 6.25% for 4 weeks. The 
result showed that root was effective in lowering FSH 
serum level in somnifera-treated animals compared to 
controls (p<0.05) in both diabetic and non-diabetic groups, 
whereas progesterone (p<0.05), testosterone (p<0.05) and 
LH levels (p<0.001) were significantly higher and 
suggested that withania somnifera may have a regulatory 
effect on diabetes-induced change of the levels of gonadal-
hormones[44].  
Discussion and Conclusion 
Plants have been traditionally used to treat 
diabetes patients, both insulin dependent & non insulin 
dependent diabetes all over the world for centuries. They 
have also been reported to be used in associated 
conditions of diabetes like diabetic ED, diabetic peripheral 
neuropathy, diabetic retinopathy etc. Recent scientifically 
carried out research work have justified the role of herbs 
in the management of diabetes, however it would be 
unwarranted to assure that all these plants can be blindly 
used in diabetic patients. Although there is an increase in 
the number of patients suffering from diabetic ED during 
the last decade. Herbs are highly esteemed for millennia as 
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a rich source of therapeutic agents for prevention and 
treatment of diabetes and its associated ailments. Hence, I 
reviewed update information regarding diabetic ED and 
many herbs traditionally being used in this condition. I 
selected only three medicinal plants which are widely used 
for Diabetic ED. On the basis of our reviewed the Rason 
(Allium sativum), Ashwagandha (Withania somnifera) and 
Ashwatha (Ficus religiosa) is responsible to decreased 
serum glucose, triglycerides, cholesterol, urea, uric acid, 
AST and ALT, while increased serum insulin level and 
showed hypoglycaemic effect attributed mainly to allicin-
type compounds and the hypoglycaemic potency of Allium 
sativum has been attributed to the sulphur compounds [di 
(2-propenyl) disulphide and 2-propenyl propyl disulphide, 
respectively]. Withania somnifera exhibited hypoglycemic 
effect due to its property to increase the level of serum 
insulin and activities of catalase, superoxide dismutase and 
glutathione peroxidase, indicative of its antioxidant 
property. Ficus religiosa have the potent hypoglycemic 
effects due to β-sitisteryl-Dglucoside; Antidiabetic 
Phytochemicals. The majority of the experiments 
confirmed the benefits of these medicinal plants with 
hypoglycemic effects in the management of diabetes. The 
mechanism of hypoglycaemic action probably involves 
direct or indirect stimulation of insulin secretion. Allium 
sativum, Withania somnifera and Ficus religiosa also 
described for sexual disability in ancient literature even 
though Ayurveda claimed its Vajikarn; to enhance sexual 
power. 
Ashwagangha is an essential constituent in 
traditional Indian medicine for the treatment of sexual 
impotence. It is likely that this effect reflects the tonic, 
restorative and adaptogenic properties. It has been shown 
that withanolides relax rabbit corpus cavernosum and this 
effect is mediated by nitric oxide, released from 
endothelial or neural cells. These endothelial and 
neurogenic effects of withanosides in inducing relaxation 
of the corpus cavernosum may account for the aphrodisiac 
effect of Ashwagandha.  
It can be concluded that these medicinal plants 
reduces blood glucose level by the hypoglycemic property 
and also having a potent aphrodisiac agent and exhibit the 
efficacy in diabetic ED. 
Further investigations or studies on these plants 
are also needed to find out their mechanism and isolation 
of newer molecules which will be helpful for the treatment 
of diabetes and erectile dysfunction. These plants should 
be subjected to animal and human studies to determine 
their effectiveness. 
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